Co-Diagnostics, Inc. Announces Construction Update at JV Manufacturing Facility in India
Project moving forward on schedule, with production to begin in Q3 2018
CoSara Diagnostics, Pvt., Ltd. (“CoSara”), the JV for manufacturing with
The documentation for the JV’s future Quality Management System, required to seek ISO certification and regulatory approvals, is currently being established, and CoSara management has recently completed meetings with regulatory consultants to finalize the procedure for obtaining the manufacturing license from the Indian government once the plant is ready for inspection.
About
Forward-Looking Statements:
This press release contains forward-looking statements.Forward-looking statements can be identified by words such as "believes," "expects," "estimates," "intends," "may," "plans," "will" and similar expressions, or the negative of these words. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions.Readers of this press release are cautioned not to place undue reliance on any forward-looking statements.The Company does not undertake any obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180322005471/en/
Source:
Company Contact:
Co-Diagnostics, Inc.
Andrew Benson
Co-Diagnostics
Investor Relations
801-438-1036
investors@codiagnostics.com
or
Investor
Contact:
Lytham Partners, LLC
Joe Diaz, Robert Blum and
Joe Dorame
602-889-9700
codx@lythampartners.com